Alexander Y. Liebeskind

Papers

Total Citations

H-Index

About

Alexander Y. Liebeskind’s research lies at the critical intersection of surgical innovation, health equity, and regulatory science. His work systematically examines how advanced technologies—particularly robotic and minimally invasive surgery—are adopted across diverse populations, revealing troubling patterns of racial and ethnic disparities in access to cutting-edge cancer treatments. In his highly cited 2023 systematic review, Liebeskind synthesized evidence showing that the benefits of robot-assisted surgery for pelvic cancers are not equitably distributed, a finding with profound implications for healthcare quality and justice. His 2022 study on the “510(k) ancestry” of robotic surgical systems is equally groundbreaking, tracing how devices like the da Vinci system enter the market through regulatory pathways originally designed for less complex technologies. By mapping these regulatory lineages, Liebeskind provides a novel framework for understanding how surgical innovation is governed and how it may inadvertently perpetuate inequities. Though early in his career, his work has already garnered significant attention, with his most-cited papers accumulating dozens of citations and shaping conversations in surgery, health policy, and bioethics. Liebeskind is a rising voice in the movement to ensure that surgical progress serves all patients equally.